NT_1170x120_1-11-18

Boehringer Ingelheim GmbH

Sanofi, Boehringer agree to $25 billion asset swap

Sanofi, Boehringer agree to $25 billion asset swap

PARIS — Sanofi has agreed to a 22.8 billion euro ($25.1 billion) asset swap with Germany’s Boehringer Ingelheim GmbH that will boost the French drug manufacturer’s business in selling over-the-counter drugs. The two companies reached a definitive agreement late Monday after announcing exclusive negotiations in December. Terms are unchanged from the original announcement: Sanofi will